Medicinal and Aromatic Plants Extracts as Well as Essential Oils Applied in the Prevention and Treatment of Various Diseases

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".

Deadline for manuscript submissions: closed (10 March 2023) | Viewed by 3091

Special Issue Editors


E-Mail Website
Guest Editor
Institute for Medicinal Plant Research “Dr Josif Pančić”, Tadeuša Košćuška 1, 11000 Belgrade, Serbia
Interests: biological activities of plant extracts and essential oils; quality control of medicinal plant-based products; genotoxicology; biological control with natural products

E-Mail Website
Guest Editor
Faculty of Biology, University of Belgrade, Studentski trg 16, 11000 Belgrade, Serbia
Interests: ecology; biological control with natural products

Special Issue Information

Dear Colleagues,

Nature has always been, and still is, a source of foods and ingredients that are beneficial to human health. Inadequate supply of drugs, the prohibitive cost of treatments, side effects of several synthetic drugs and the development of resistance to currently used drugs for infectious diseases have led to increased emphasis on the use of plant materials as a source of medicines for a wide variety of human ailments. Treatment with medicinal plants is considered very safe as there are no or minimal side effects.

Nowadays, medicinal plants and their extracts and essential oils play vital roles in disease prevention and their promotion and use fit into all existing prevention strategies. Due to their natural origin, they are excellent candidates to replace synthetic compounds, which are generally considered to have toxicological and carcinogenic effects. The efficient extraction of these compounds from their natural sources and the determination of their activity in commercialized products have been great challenges for researchers and food chain contributors to develop products with positive effects on human health.

The objective of this Special Issue is to highlight the existing evidence regarding the various potential benefits of the consumption of plant extracts and plant extract-based products, along with essential oils for the prevention and treatment of various disorders in humans. The aim is to point out the role, contributions, and usefulness of medicinal plants in tackling diseases of public health importance.

This Special Issue aims to collect contributions, research papers, and reviews related to the possibility of using medicinal and aromatic plant extracts, as well as their essential oils in reducing the damage to various tissues and organs of diabetic patients and diabetics that occurs as accompanying chronic complications.

We look forward to receiving your contributions.

Dr. Tatjana Stević
Dr. Slaviša Stanković
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diabetes mellitus (DM)
  • antidiabetic agents
  • medicinal plant extracts
  • aromatic plant extracts
  • essential oils

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

35 pages, 3904 KiB  
Review
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era
by Daniel Mieres-Castro and Freddy Mora-Poblete
Pharmaceutics 2023, 15(2), 348; https://doi.org/10.3390/pharmaceutics15020348 - 20 Jan 2023
Cited by 13 | Viewed by 2611
Abstract
In the post-COVID-19 pandemic era, the new global situation and the limited therapeutic management of the disease make it necessary to take urgent measures in more effective therapies and drug development in order to counteract the negative global impacts caused by severe acute [...] Read more.
In the post-COVID-19 pandemic era, the new global situation and the limited therapeutic management of the disease make it necessary to take urgent measures in more effective therapies and drug development in order to counteract the negative global impacts caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its new infectious variants. In this context, plant-derived saponins—glycoside-type compounds constituted from a triterpene or steroidal aglycone and one or more sugar residues—may offer fewer side effects and promising beneficial pharmacological activities. This can then be used for the development of potential therapeutic agents against COVID-19, either as a therapy or as a complement to conventional pharmacological strategies for the treatment of the disease and its prevention. The main objective of this review was to examine the primary and current evidence in regard to the therapeutic potential of plant-derived saponins against the COVID-19 disease. Further, the aim was to also focus on those studies that highlight the potential use of saponins as a treatment against SARS-CoV-2. Saponins are antiviral agents that inhibit different pharmacological targets of the virus, as well as exhibit anti-inflammatory and antithrombotic activity in relieving symptoms and clinical complications related to the disease. In addition, saponins also possess immunostimulatory effects, which improve the efficacy and safety of vaccines for prolonging immunogenicity against SARS-CoV-2 and its infectious variants. Full article
Show Figures

Graphical abstract

Back to TopTop